- Home
- IMXI vs LYEL Comparison
IMXI vs LYEL Comparison
Compare IMXI & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMXI | LYEL |
|---|---|---|
| Founded | 1994 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.3M | 490.1M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMXI | LYEL |
|---|---|---|
| Price | $15.87 | $24.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $15.00 | ★ $30.60 |
| AVG Volume (30 Days) | ★ 325.3K | 76.6K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $319,601,000.00 | $36,000.00 |
| Revenue This Year | $0.83 | N/A |
| Revenue Next Year | $1.49 | $16,285.34 |
| P/E Ratio | $14.64 | ★ N/A |
| Revenue Growth | ★ 16.68 | N/A |
| 52 Week Low | $8.58 | $0.39 |
| 52 Week High | $15.90 | $45.00 |
Technical Indicators
Market Signals| Indicator | IMXI | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 62.02 |
| Support Level | $15.78 | $21.27 |
| Resistance Level | $15.90 | $27.30 |
| Average True Range (ATR) | 0.04 | 1.66 |
| MACD | -0.00 | 0.57 |
| Stochastic Oscillator | 72.00 | 97.76 |
Price Performance
Historical ComparisonAbout IMXI International Money Express Inc.
International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.